Surfix is redefining point-of-care diagnostics with an innovative Photonic Diagnostic Platform; a multi-modal solution that combines superior precision for protein detection over current lab-testing platforms with the speed and simplicity of point-of-care testing. As a rapidly growing startup, our focus is on strategic partnerships for co-developing immunoassays with diagnostic, biomarker discovery, and biopharmaceutical companies and then expanding our platform to include molecular and combined capabilities.

The core of Surfix’s photonic diagnostics platform is a photonic biosensor consisting of a photonic biochip and a microfluidic cartridge both optimized with Surfix’s proprietary nanocoatings. The biosensor is used in combination with a dedicated desktop reader.